ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,547Medicare Part D Prescriptions Filled, Including Refills

Rank: 257 out of 2429

$806K Total Retail Price of All Prescriptions

Rank: 84 out of 2429

184 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 184 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

19% of this provider’s 184 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,373 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 337 323 1 1
AMLODIPINE BESYLATE 283 245 2 4
WARFARIN SODIUM 280 280 3 11
OMEPRAZOLE 279 245 4 7
LISINOPRIL 217 187 5 2
FUROSEMIDE 203 189 6 5
LOVAZA 202 192 7 134
METOPROLOL TARTRATE 199 166 8 9
ZOLPIDEM TARTRATE 183 182 9 28
CRESTOR 181 126 10 25
LEVOTHYROXINE SODIUM 172 144 11 3
DIOVAN 161 159 12 36
ATENOLOL 156 151 13 15
LIDODERM 150 150 14 109
ATORVASTATIN CALCIUM 145 141 15 13
NEXIUM 141 127 16 37
NAMENDA 129 124 17 35
ALENDRONATE SODIUM 128 119 18 20
METOPROLOL SUCCINATE 126 107 19 12
DONEPEZIL HCL 115 99 20 26
CARVEDILOL 107 103 21 21
ISOSORBIDE MONONITRATE ER 99 99 22 55
RANITIDINE HCL 98 92 23 24
LANSOPRAZOLE 97 94 24 163
EXELON 92 92 25 132
METFORMIN HCL ER 91 62 26 65
IBUPROFEN 84 77 27 57
POLYETHYLENE GLYCOL 3350 83 69 28 56
SUBOXONE 82 13 29 199
TAMSULOSIN HCL 80 80 30 29
DIOVAN HCT 76 68 31 83
CELEBREX 75 66 32 97
POTASSIUM CHLORIDE 74 55 33 14
HYDROCODONE-ACETAMINOPHEN 73 67 S3 34 6
ESCITALOPRAM OXALATE 68 64 35 74
CLONIDINE 67 67 36 362
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 56 37 27
GABAPENTIN 63 58 38 18
MIRTAZAPINE 61 53 39 63
LEVOTHROID 61 59 39 281
METFORMIN HCL 60 34 41 8
MECLIZINE HCL 59 49 42 131
FLUTICASONE PROPIONATE 59 51 42 39
CLOPIDOGREL 58 56 44 31
TRAMADOL HCL 57 46 45 17
CITALOPRAM HBR 55 54 46 19
KETOCONAZOLE 55 42 46 194
SPIRONOLACTONE 54 54 48 62
KLOR-CON M20 53 45 49 60
GLIMEPIRIDE 52 52 50 51
DILTIAZEM 24HR ER 52 52 50 137
AZITHROMYCIN 51 41 52 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.